Sudomotor dysfunction in patients recovered from COVID-19.
Neurophysiol Clin
; 51(2): 193-196, 2021 Mar.
Article
in English
| MEDLINE | ID: covidwho-1046195
ABSTRACT
Dysautonomia has been reported in COVID-19. Sweat function testing has been proposed to assess autonomic neuropathy. Fifty Indian patients consulting for neurological symptoms participated in this observational study. The NHS questionnaire for neurological symptoms was completed and electrochemical skin conductance was measured using Sudoscan. The 26% of patients with sweat dysfunction i) were older (pâ¯=â¯0.001), ii) were more frequently treated at home (pâ¯=â¯0.008), iii) were more likely to have received antiviral treatment (pâ¯=â¯0.0006), and iv) more frequently reported at least one motor, sensory or autonomic symptom (pâ¯=â¯0.04). This preliminary study suggests that patients with COVID-19 should be screened for dysautonomia.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Autonomic Nervous System Diseases
/
Sweating
/
COVID-19
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
/
Young adult
Country/Region as subject:
Asia
Language:
English
Journal:
Neurophysiol Clin
Journal subject:
Physiology
/
Neurology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS